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Abstract   
      Metabolic syndrome (MS)  is a group of clinical and biological abnormalities included risk of insulin 
resistance , disorders in glucose metabolism ,  abdominal obesity and abnormal lipid profile these features confer 
a greater risk of cardiovascular diseases . Anyway, the co-occurrence of diabetes mellitus and metabolic 
syndrome potentiates the cardiovascular risk associated with each of the two conditions. The present study aimed 
to determine a relationship between prolactin level in type -2- diabetic Iraqi women and metabolic syndrome, as 
well to find a relationship between prolactin level and other studied biochemical markers. seventy menopausal 
diabetic women with metabolic syndrome with age in range (45-50) years were enrolled in this study , and were 
compared with matched age control group which consisted of menopausal  women suffering from uncomplicated 
diabetic patients (without metabolic syndrome ). Two groups were not given any treatment ,  they  were newly 
diagnosed. This study highlights the role of metabolic syndrome in the abnormalities of  prolactin blood glucose 
, lipid profile , glycated hemoglobin and body mass index regardless the role of diabetic mellitus. Available 
evidence from the present study have reported that prolactin is a novel biochemical marker in sera of Iraqi 
menopausal type-2 diabetic women with metabolic syndrome . Moreover this study is the first highlights not 
only the association between lower level prolactin and metabolic syndrome in type-2 diabetic women but also 
the correlation between lower prolactin level and other biochemical markers ( Lipid profile , HbA1c and BMI ) in 
type-2- diabetic women with metabolic syndrome .  
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1.0  Introduction   
    Metabolic syndrome is a collection of medical conditions that can lead to obesity , insulin resistance , 
cardiovascular disease and hypertension , The prevalence of metabolic syndrome is on a rapid rise due to the 
shifted paradigm of diet and lifestyle and thus has afflicted  many people worldwide (1) , there is still lack of 
clearly defined pathophysiology and universal definition of metabolic syndrome . Many researchers question is 
own existence as a specific syndrome that predisposes on individual to particular risk . This has led to several 
definitions for metabolic syndrome being proposed by various interventional regulatory bodies. World health 
organization (WHO) defines this syndrome as the presence of glucose intolerance or insulin resistance of 
diabetics mellitus with any two of the following components: obesity , high serum TG , low HDL-c and 
hypertension (2). Type-2 diabetes ,  a scientifically more challenging disease which is characterized by elevated 
insulin resistance and glucose intolerance . However type 11 diabetes occur as a result of a defect in glucose , 
lipid and energy homeostasis in organs / systems such as liver , muscle , adipose tissue and gastrointestinal tract . 
The imbalances in lipid and carbohydrate metabolism cause high levels of serum glucose and free fatty acids 
which in turn lead to endoplasmic reticular stress in pancreatic beta cells and consequent death (3) . Prolactin is a 
polypeptide hormone mainly secreted from the auterior pituitary gland and regulated by tonic inhibition of the 
hypothalamus via dopamine (4,5) . It has been primarily identified as a major stimulatory factor for lactation in 
the post-partum period prolactin acts through receptors called PRO receptors (PRL_Rs ) which are induced as 
members of the cytokine receptor super family , distributed throughout the immune system monocytes , 
macrophages , T and B cells , NK cells . Indeed , the relationship between prolactin and immune system has 
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been demonstrated in the last two decades and has opened new windows in the field of neuro _immuno  
endocrinology (4). Broadly , in most of previous studies , the correction between prolactin and cardio metabolic 
risk factors including metabolic syndrome or type -2- diabetes mellitus were not the main focus . Furthermore, 
previous studies were conducted in comparably small and selected patient population without consideration of 
major confounding factors  (6) . Total cholesterol  (TC) represents the total serum cholesterol , it is a necessary 
molecule in human metabolism , cholesterol is present in the blood in three forms , high density lipoproteins 
(HDL-c) , low density lipoproteins (LDL-c) and  Very low density lipoproteins (VLDL-C) (7,8) . Triacylglycerol 
(TG) are lipids carried through the blood stream to tissues it is a type of fat the body uses to store energy and 
give energy to muscles , (7, 9) HDL-c is commonly known as the “good “ cholesterol from building up in the 
arteries , HDL-c is composed of a high proportion of protein with little triacylglycerol and cholesterol , HDL, are 
involved in reverse cholesterol transport , which is believed to protect against heart diseases and stroke , while 
LDL-c is sometimes referred to as “ bad” cholesterol , this form contains the highest amount of cholesterol , for 
this reason , LDL-c commonly known as the “ bad “ cholesterol they contribute to the buildup of plaque within 
the arteries (7,8). Very low density lipoproteins (VLDL-c) contains very little protein , the main purpose of 
VLDL-c is to distribute the triacylglycerol produced by liver , A high VLDL-c level can cause the buildup of 
cholesterol in the arteries and increase risk of heart diseases and stroke (9).  Body mass index (BMI) is 
recommended by WHO as a simple marker to reflect total body fat amount. However, BMI  as compared to 
weight and height is just an index of weight excess rather than body fatness composition (10). Glycated 
hemoglobin  (HbA1c) is formed by posttranslational , non-enzymatic , substrate concentration dependent 
irreversible process of combination of aldehyde group of glucose and other hexoses with the amino terminal 
value of the β-chain of hemoglobin (11). Formation of HbA1c is irreversible and the level in Red blood cells 
depends on the blood glucose concentration  (12) , HbA1c is a form of hemoglobin used primarily to identify  
the average plasma glucose concentration over a prolonged period of time . An increased level of glycated 
hemoglobin has been associated with cardiovascular disease and diabetes mellitus (6). 
 
2.0 Materials and Methods 
 
2.1  Subjects 
     In the present  study , (70) menopausal women with age in range (45-50) years  were enrolled in this study , 
they have undergone many  tests that diagnosed them as diabetic patients with metabolic syndrome , they were 
newly diagnosed and not given any treatment related to diabetic mellitus or cardiovascular diseases , those 
patients were compared with a control group consisted of also (70) menopausal  women with matched age , they 
were suffering from diabetes mellitus without any complications such as atherosclerosis and cardiovascular 
diseases. Blood samples were collected from The National center of Diabetes Treatment and Researches related 
to Al-Mustansirya university in Baghdad. 
 
2.2   Blood  Sampling , parameter determination and calculations 
   Five milliliters (5 mL) of venous blood were collected from all subjects erolled in this study , placed into plain 
tubes until coagulation was performed . Serum was separated from blood cells by centrifugation at 4000 r.p.m 
for 2 min , subsequently serum was divided  into  small portions and kept frozen (-20 ο C) until analysis , while 
erythrocytes were used directly to measure HbA1c. Determination of prolactin was performed by Enzyme 
Linked Immunosorbent Assay (ELISA)  for direct antigen detection using high affinity of  Biotin for streptavidin 
which has been coated on the surface of microliter walls , the absorbance was measured at 450 nm. TC and TG 
were determined by enzymatic methods while HDL-c was determined by precipitation methods , LDL-c and 
VLDL-c were determined by calculations (13). 
 
LDL-c (mg/dL)  = TC – ( HDL-c + TG/5) 
VLDL-c  (mg/dL)  = TG/5 
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   HbA1c was calculated using ion exchange high performance liquid chromatography (HPLC) . Furthermore, 
women passed through physical examination including weight and height assessment to determine body mass 
index (BMI)  which was calculated in accordance with this equation (14).  
BMI = (weight / kg) / (height m2) 
 
2.3  Statistical Analysis 
  Results were expressed as mean ±SD ( SD : Standard deviation). Student t-test was used to compare the 
significance of the difference between the studied and control groups . Probability (p-value )  (p<0.001) , 
(p<0.01) , (p<0.05) are statistically considered  highly significant , significant and non-significant respectively . 
The correlation  coefficient (r) test is used for describing the positive or negative relationship between prolactin 
and other studied biochemical parameters. 
  
 3.0  Results 
    Data in table -2- have revealed  that prolactin level was significantly decreased (p<0.01) in sera of diabetic 
patients with MS (17.98±8.45) µU / mL compared with  diabetic patients without MS (22.87±.78)µU / mL. 
Moreover , results have suggested that fasting blood sugar was  significant increase (p<0.01) in sera of diabetic 
patients with MS (190.94±40.23) mg/dL compared with diabetic patients without MS (119.1±30.12) mg/dL. 
Furthermore , a non significant  increase (P<0.05) was  shown in HbA1c level in diabetic patients with MS 
(10.16±1.616)%  compared with diabetic patients without MS (7.03±1.14)% . On the other hand , data in table -
2- have revealed that TC level was significantly increase (p<0.01) in sera of diabetic patients with MS 
(207.05±39.15) mg/dL in comparison with diabetic patients without MS (196.83±33.59) mg/ dL , also a 
significant increase (p<0.01) was noticed inTG level (0.01) in sera of diabetic mellitus with MS (186.04±45.6) 
mg / dL compared with diabetic mellitus without MS (120±23.3) mg/dL. Convesely m HDL-c was significantly 
decrease (p<0.01) in sera of diabetic patients in MS (40.48±3.3) mg/dL compared with diabetic patients without 
MS (46.59±2.5) mg/dL , while a non-significant increase (p<0.05) was shown in LDL-c level in sera of diabetic 
patients with MS ( 138.56±33.9) mg/dL compared with diabetic patients without MS (129.47±28.33) mg/dL. 
Also , VLDL-c level was non significantly increase (p<0.05) in sera of diabetic patients with MS (28.35±7.98) 
mg/dL compared with diabetic patients without  MS (21.06±6.23) mg/dL. Lastly  , BMI was highly significant 
increase (p<0.01) in diabetic patients with MS (31.19±5.79) kg / m2 compared with diabetic patients with MS  
(25.93±4.21) kg/m2. compared with diabetic patients with MS (25.93±4.21) kg/m2. Results of table -3- indicate 
results of  table-1- and table -2- . It suggests a positive correlation between prolactin and (FBS , TC , TG , LDL-c 
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Table 1   Prolactin level (µL/mL) , Fasting blood sugar (FBS) (mg/dL) and glycated hemoglobin                                     








With  metabolic                                     
syndrome P value 
Mean ±SD Mean±SD 
Prolactin 
(µL/mL) 
22.87±4.78 17.98±8.45 P<0.01 
Fasting Blood Sugar 
(mg/dL) 
119.1±30.12 190.94±40.23 P<0.01 
HbA1c 
(%) 
7.03±1.14 10.16±1.46 P<0.05 
 
 
Table 2   Total cholesterol (TC) , Triacylglycerol (TG) , high density lipoprotein cholesterol  
                (HDL-c) , low density lipoprotein cholesterol (LDL-c) , Very low density lipoprotein  







     With metabolic                     
        syndrome P value 
Mean ±SD Mean ±SD 
TC  
(mg/dL) 
196.38±33.59 207.05±39.15 P<0.01 
TG 
(mg/dL) 
120.4±23.3 186.04±45.6 P<0.01 
HDL-c 
(mg/dL) 
46.59±2.5 40.48±3.3 P<0.01 
LDL-c 
(mg/dL) 
129.47±28.33 138.56±33.9 P<0.05 
VLDL-c 
(mg/dL) 
21.06±6.23 28.35±7.98 P<0.05 
BMI  
( kg/m2) 
25.93±4.21 31.19±5.79 P<0.01 
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Table 3  Correlation between prolactin and ( TC , TG , HDL-c , LDL-c , VLDL-c , FBS and    
               HbA1c) in sera of diabetic patients with MS. 
 
Parameter Correlation coefficient 
(r) with prolactin (µL/mL) 
P value 
FBS (mg/dL) +0.530 P<0.001 
TC (mg/dL) +0.390 P<0.05 
TG (mg/dL) +0.445 P<0.001 
HDL-c (mg/dL)       -0.690 P<0.001 
LDL-c (mg/dL) +0.313 P<0.05 
VLDL-c (mg/dL) +0.309 P<0.05 
HbA1c (%) +0.143 P<0.05 
 
4.0  Discussion 
 Prolactin is a pituitary hormone essential for various physiological functions in the human body. It is not only 
important for the initiation and maintenance of lactation, but also seems to be involved in reproduction growth 
and development , osmoregulation , immune regulation , brain function , behavior and metabolism (3,6) . The 
wide expression of prolactin receptors in different tissues and cells such as lymphoid cells , prostate , 
endometrium , and adipocytes , further suggests the different functions of prolactin (3). Metabolic syndrome 
represents a cluster of conditions including glucose intolerance, hypertension, dyslipidemia and insulin 
resistance (1). Prolactin generally is secreted from pituitary gland (4,5). In this regard, a recent study has linked 
between hypopituitarism (that lead to lower level of prolactin ) and metabolic syndrome (15). This discussion 
give a good support to our results related to prolactin in sera of diabetic patients with metabolic syndrome 
compared with diabetic patients without metabolic syndrome. As observed from many studies, metabolic 
syndrome is associated with insulin resistance , elevated glucose and lipids , inflammation , decreased 
antioxidant activity and hypertension (1,16). These suggestions give a good indication to our results concerned 
with high fasting blood sugar in sera of diabetic patients with metabolic syndrome compared with diabetic 
patients without metabolic syndrome. Further, a previous study has shown that the metabolic changes that 
accompanies hypothyroidism are central obesity, hyperlipidemia, and insulin resistance. These metabolic 
changes are principally thought to be due to Growth hormone deficiency, although altered insulin – like growth 
factor -1 , cortisol and gonadotropin metabolism has been implicated. Adult patients with anterior pituitary 
deficiency and associated growth hormone deficiency have fatty filtration of the liver more frequently than 
patients with anterior pituitary hormone deficiency without growth hormone deficiency (17) , this study gives a 
good explanations to our results. Glycated hemoglobin (HbA1c) is widely accepted as a useful measure of mean 
blood glucose and therapeutic guideline of diabetes. HbA1c is a form of hemoglobin that is measured primarily 
to identify the average plasma glucose concentration over prolonged period time. Even though insulin resistance 
is one of the major etiological factors in the development of metabolic syndrome , direct quantitative 
measurement of insulin sensitivity is not readily available and this cannot be used as the diagnostic tool for the 
syndrome. therefore , various diagnostic criteria for metabolic syndrome have been suggested. It is shown that 
patients with high HbA1c  significantly define metabolic syndrome (18) , this study has a good agreement with 
our results related to the higher level of HbA1c in diabetic patients with metabolic syndrome compared with 
diabetic patients without metabolic syndrome.  On the other hand , Dyslipidemia is one of the metabolic risk 
factors included in metabolic syndrome (19). Hypercholesterolemia is one of the different forms of dyslipidemia 
, it indicates elevated blood cholesterol. Excess cholesterol builds up in the walls of the arteries, overtime m this 
buildup contributes to the atherosclerosis , a disease process in which arteries become narrowed and blood flow 
is impaired (7) , therefore total cholesterol was increased in sera of diabetic patients with metabolic syndrome. 
Low HDL-c was most frequent while hypertriglyceridemia was least frequent. Abdominal obesity was the 
second most prevalent factor. This combination of abdominal obesity and low HDL-c was also reported as the 
most common combination among Chinese type-2- diabetic patients with metabolic syndrome (2). As well , 
Journal of Natural Sciences Research                                                                                                                                                www.iiste.org 
ISSN 2224-3186 (Paper)   ISSN 2225-0921 (Online) 
Vol.5, No.16, 2015 
 
134 
Another previous study has suggested that dyslipidemia is a characteristics of the metabolic syndrome which 
consists of a group of coronary heart disease risk factors that includes higher levels of glucose intolerance ( FBS) 
, TG and lower levels of  HDL-c (7) . The simple calculated measure of TG/HDL ratio has been identified as a 
predictor of insulin resistance and cardiovascular disease and may also be a useful marker of atherogenic 
lipoprotein profile, enabling them to identify patients who may be at higher risk of metabolic disturbances (26) 
Three studies cited previously give a good support to our results related to high TG level , low HDL-c  level , 
high BMI and high FBS in diabetic patients with metabolic syndrome. It has suggested that , in diabetic patients 
with complications (i.e. suffering from metabolic  syndrome ) , a non-invasive screening for cardiovascular 
disease is currently recommended . In contrast , in patients without complications , it is very difficult to identify 
subjects for screening (21). A recent study has revealed that metabolic syndrome accompanied type-2- diabetic 
patients exhibit a characteristic pattern of abnormalities in serum lipid , dyslipidemia is also characterized by a 
shift of LDL-c pool toward small , dense  LDL-c particles that are cholesteryl ester depleted , this reflect the 
higher level of LDL-c in sera of diabetic patients with metabolic syndrome compared with metabolic syndrome 
compared with diabetic patients without metabolic syndrome (22). In this regard , metabolic syndrome include 
risk factors in adipose tissue dysfunctions and insulin resistance which leads to increase in circulating free fatty 
acids (FFA) . Increased FFA delivery to the  liver increase hepatic secretion and triacylglycerol enrichment of 
very low density lipoprotein cholesterol (23). This  study  agree with our results related to the increase in LDL-c 
and VLDL-c level in sera of diabetic patients with metabolic syndrome compared with diabetic patients without 
metabolic syndrome. Further , a recent study has suggested that VLDL particles concentration is elevated in 
metabolic syndrome along with increased large (approximately three fold ) and medium ( approximately two 
fold ) VLDL particles and that LDL-c concentration is increased as well , along with increased small LDL 
particles (24). At this point , central abnormalities of dyslipidemia are increased in apoB- carrying lipoproteins 
and decrease in apolipoprotein A-I lipoproteins . It is believed that this complex dyslipidemia , which is termed 
atherogenic dyslipidemia , diabetic dyslipidemia or dyslipidemia of insulin resistance , reflects underlying 
insulin resistance and plays a key role in the increased cardiovascular risk in patients with type-2- diabetic 
mellitus (22). Interestingly, Hypopituitarism (which lead to low secretion of prolactin) is associated with a 
complex metabolic impairment and insulin resistance, this recent study highlights the impact of hypopituitarism 
with regard to BMI and lipid profile by resulting worse than in non hypopituitaric patients , (25) consequently 
this study indicate the positive correlation between prolactin and (BMI  , TC , TG , LDL-c ) and the negative 
correlation between prolactin and HDL-c. Lastly, recent reports have focused on the role of leptin. Leptin levels 
are significantly increased among patients with hypopituitarism compared with BMI and body fat content- 
matched control (17). These results strongly indicate the elevation of BMI in diabetic patients with lower 
prolactin level ( with metabolic syndrome) compared with diabetic patients without metabolic syndrome. 
 
5.0  Conclusions  
   Prolactin could be considered a good biochemical marker for Iraqi menopausal women with metabolic 
syndrome accompanied by type-2- diabetes mellitus. Moreover, this is the first study in Iraq reported an 
association between low level of prolactin and type -2- diabetic patients with metabolic syndrome. 
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